VA

VR Adviser Portfolio holdings

AUM $1.33B
This Quarter Return
+19.93%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$1.33B
AUM Growth
+$1.33B
Cap. Flow
-$26.3M
Cap. Flow %
-1.97%
Top 10 Hldgs %
74.55%
Holding
40
New
3
Increased
4
Reduced
7
Closed
9

Top Buys

1
ORIC icon
Oric Pharmaceuticals
ORIC
$34.7M
2
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$32.2M
3
CTMX icon
CytomX Therapeutics
CTMX
$31.7M
4
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
$21.9M
5
SVRA icon
Savara
SVRA
$12.8M

Top Sells

1
PRAX icon
Praxis Precision Medicines
PRAX
$37.5M
2
CDTX icon
Cidara Therapeutics
CDTX
$20.1M
3
PHVS icon
Pharvaris
PHVS
$18.7M
4
DNTH icon
Dianthus Therapeutics
DNTH
$13.9M
5
SLDB icon
Solid Biosciences
SLDB
$9.18M

Sector Composition

1 Healthcare 99.4%
2 Financials 0.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SEPN
26
Septerna, Inc. Common Stock
SEPN
$628M
$5.71M 0.43%
+540,453
New +$5.71M
SRZN icon
27
Surrozen
SRZN
$107M
$5.66M 0.42%
632,931
– –
ZURA icon
28
Zura Bio
ZURA
$132M
$4.86M 0.36%
4,631,216
-391,950
-8% -$412K
ARTV
29
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$77.5M
$2.43M 0.18%
1,609,569
– –
CASI icon
30
CASI Pharmaceuticals
CASI
$36.1M
$1.16M 0.09%
987,259
– –
TENX icon
31
Tenax Therapeutics
TENX
$27.5M
$568K 0.04%
98,564
-109,769
-53% -$632K
APLT icon
32
Applied Therapeutics
APLT
$73.7M
– –
-5,567,709
Closed -$2.72M
FDMT icon
33
4D Molecular Therapeutics
FDMT
$287M
– –
-677,600
Closed -$2.19M
IPSC icon
34
Century Therapeutics
IPSC
$40.4M
– –
-2,498,069
Closed -$1.19M
MRSN icon
35
Mersana Therapeutics
MRSN
$34.8M
– –
-142,973
Closed -$1.23M
PRAX icon
36
Praxis Precision Medicines
PRAX
$980M
– –
-989,985
Closed -$37.5M
SLDB icon
37
Solid Biosciences
SLDB
$448M
– –
-2,481,400
Closed -$9.18M
TIL icon
38
Instil Bio
TIL
$196M
– –
-33,177
Closed -$576K
TNYA icon
39
Tenaya Therapeutics
TNYA
$192M
– –
-1,555,556
Closed -$887K
TRVI icon
40
Trevi Therapeutics
TRVI
$871M
– –
-615,506
Closed -$3.87M
1
2